BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 905317)

  • 1. Diet-induced hyperuricaemia and platelet aggregation in rats.
    Winocour PD; Munday KA; Taylor TG; Turner MR
    Proc Nutr Soc; 1977 Sep; 36(2):86A. PubMed ID: 905317
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet aggregation in rats made hyperuricaemic with nucleic adid-rich diets containing oxonate, and inhibitor of uricase [proceedings].
    Winocour PD; Munday KA; Taylor TG; Tuner MR
    Proc Nutr Soc; 1976 Sep; 35(2):54A-55A. PubMed ID: 972878
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet aggregation in rats in relation to hyperuricaemia induced by dietary single-cell protein and to protein deficiency.
    Winocour PD; Turner MR; Taylor TG; Munday KA
    Thromb Haemost; 1978 Apr; 39(2):346-59. PubMed ID: 580986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation in serum uric acid of rats fed potassium oxonate.
    Newburger J; Combs AB; Hsu TF
    Drug Chem Toxicol; 1978; 1(3):231-5. PubMed ID: 573681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allantoxanamide: a potent new uricase inhibitor in vivo.
    Johnson WJ; Chartrand A
    Life Sci; 1978 Nov; 23(22):2239-44. PubMed ID: 723476
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant polyarthritis. VI. Effect of oxonate-induced hyperuricemia on the development of acute inflammation, immune response and adjuvant arthritis.
    Chang YH; Bluestone R
    J Pharmacol Exp Ther; 1981 Dec; 219(3):731-4. PubMed ID: 6975369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High steady-state levels of uric acid produced in rats by dietary training and potassium oxonate.
    Newburger J; Hsu TF; Combs AB
    J Pharm Sci; 1979 May; 68(5):651-2. PubMed ID: 430510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological characteristics of various experimental models for the study of disorders in purine metabolism.
    Musil J
    Adv Exp Med Biol; 1977; 76B():179-88. PubMed ID: 16457
    [No Abstract]   [Full Text] [Related]  

  • 9. Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate.
    Stavric B; Clayman S; Gadd RE; Hébert D
    Pharmacol Res Commun; 1975 Apr; 7(2):117-24. PubMed ID: 1144488
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of fructose administration on serum urate levels in the uricase inhibited rat.
    Stavric B; Johnson WJ; Clayman S; Gadd RE; Chartrand A
    Experientia; 1976 Mar; 32(3):373-4. PubMed ID: 1253916
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxonate-induced hyperuricemia and orotic aciduria in mice.
    Mangoff SC; Milner JA
    Proc Soc Exp Biol Med; 1978 Jan; 157(1):110-5. PubMed ID: 622363
    [No Abstract]   [Full Text] [Related]  

  • 12. Uricostatic effect of allopurinol in the allantoxanamide-treated rat: a new method for evaluating antiuricopathic drugs.
    Hropot M; Muschaweck R; Klaus E
    Adv Exp Med Biol; 1984; 165 Pt A():175-8. PubMed ID: 6720375
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperuricemia and locomotor activity in developing rats.
    Barrera CM; Hunter RE; Dunlap WP
    Pharmacol Biochem Behav; 1989 Jun; 33(2):367-9. PubMed ID: 2813475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allantoxanamide-induced myocardial necrosis in Sprague-Dawley vs spontaneously hypertensive rats.
    Wexler BC
    Proc Soc Exp Biol Med; 1982 Sep; 170(4):476-85. PubMed ID: 7122477
    [No Abstract]   [Full Text] [Related]  

  • 15. Uric acid kidney stones induced in rats by oxonic acid, a uricase inhibitor.
    Stavric B; Nera EA; Johnson WJ; Salem FA
    Invest Urol; 1973 Jul; 11(1):3-8. PubMed ID: 4724271
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of adjuvant arthritis by oxonate: influence of uricemia (author's transl)].
    Lussier A; de Médicis R; Mathon G
    Experientia; 1978 Aug; 34(8):995-6. PubMed ID: 700052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
    Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
    J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological effects of 1,3,5-triazines and their excretion characteristics in the rat.
    Hropot M; Sörgel F; von Kerékjártó B; Lang HJ; Muschaweck R
    Adv Exp Med Biol; 1980; 122A():269-76. PubMed ID: 6893515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental nephropathy caused by hyperuricemia in rats. Preliminary observations].
    Chériè Lignière G; Carrabba M; Multeni M; Colombo B
    Reumatismo; 1977; 29(2-3):120-4. PubMed ID: 616958
    [No Abstract]   [Full Text] [Related]  

  • 20. A preliminary report of nephropathy in hyperuricemic rats.
    Waisman J; Bluestone R; Klinenberg JR
    Lab Invest; 1974 Jun; 30(6):716-22. PubMed ID: 4835598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.